Flagship Pioneering Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
⚲
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Flagship Pioneering Inc
✚
CIK #0001400240
Sector Form 13F Holdings Value ($B)
Moderna Inc 0.2
SANA Biotechnology Inc 0.1
Foghorn Therapeutics Inc 0.1
Seres Therapeutics Inc 0.0
 
 
 
 
 
 
 
Holdings by Sector ($B)
10.08.06.04.02.00.02013201720222027
EDGAR Form CIK 2011 - 2026
13F-HR [0001400240]
3 [0001400240]
4 [0001400240]
SC 13G [0001400240]
Form 13D/13G Filer Form 13D/13G Subject Filed
Flagship Pioneering LLC Generate Biomedicines Inc [2026-05-15]
Form 3/4/5 Subject 2011 - 2026
Generate Biomedicines Inc
Flagship Pioneering Special Opportunities Fund II General Pa
FPN General Partner LLC
Flagship Pioneering LLC
Flagship VentureLabs VI Manager LLC
Nutritional Health LTP Fund General Partner LLC
Afeyan Noubar
Flagship Pioneering Fund VI General Partner LLC
Flagship Pioneering Fund VII General Partner LLC
Flagship Ventures Fund V LP
Flagship Ventures Opportunities Fund I LP
Flagship Pioneering Special Opportunities Fund II LP
Flagship Ventures Fund V General Partner LLC
Flagship Pioneering Fund VII LP
Foghorn Therapeutics Inc
Flagship Ventures Opportunities Fund I General Partner LLC
Sana Biotechnology Inc
Flagship VentureLabs V Manager LLC
Flagship V VentureLabs Rx Fund LP
Flagship Pioneering Fund VI LP
Flagship VentureLabs V LLC
Sigilon Therapeutics Inc
Evelo Biosciences Inc
Flagship Ventures Fund IV LP
Nutritional Health LTP Fund LP
Flagship Ventures Fund IV General Partner LLC
Omega Therapeutics Inc
FPA General Partner LLC
Axcella Health Inc
FPA LP
Seres Therapeutics Inc
Flagship Ventures Fund IV-RX LP
FPN LP
Codiak BioSciences Inc
Nutritional Health Side Fund LP
Kaleido Biosciences Inc
Nutritional Health Disruptive Innovation Fund LP
Flagship VentureLabs IV LLC
Moderna Inc
Kania Edwin
AGTC Partners LP
AGTC Advisors Fund LP
NewcoGen Group Inc
BG Medicine Inc
Applied Genomic Technology Capital Fund LP
Flagship Ventures 2007 General Partner LLC
Flagship Ventures Fund 2007 LP
Newcogen Group LLC
Newcogen Equity Investors LLC
ST NewcoGen LLC
NewcoGen Long Reign Holding LLC
Acceleron Pharma Inc
NewcoGen Elan LLC
NewcoGen PE LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Generate Biomedicines Inc GENB
Common Stock
2026-03-02 Conversion 13,702,224
Generate Biomedicines Inc GENB
Common Stock
2026-03-02 Buy 1,562,500 $16.00 25,000,000
Generate Biomedicines Inc GENB
Common Stock
2026-03-02 Conversion 2,777,752
Generate Biomedicines Inc GENB
Common Stock
2026-03-02 Conversion 2,777,752
Generate Biomedicines Inc GENB
Common Stock
2026-03-02 Buy 1,562,500 $16.00 25,000,000
Generate Biomedicines Inc GENB
Common Stock
2026-03-02 Buy 1,562,500 $16.00 25,000,000
Generate Biomedicines Inc GENB
Series C Preferred Stock · derivative
2026-03-02 Conversion 1,265,822 $0.00
Generate Biomedicines Inc GENB
Series C Preferred Stock · derivative
2026-03-02 Conversion 2,109,704 $0.00
Generate Biomedicines Inc GENB
Series B Preferred Stock · derivative
2026-03-02 Conversion 843,881 $0.00
Generate Biomedicines Inc GENB
Series B Preferred Stock · derivative
2026-03-02 Conversion 2,109,704 $0.00
Generate Biomedicines Inc GENB
Common Stock
2026-03-02 Conversion 12,723,940
Generate Biomedicines Inc GENB
Series A Preferred Stock · derivative
2026-03-02 Conversion 18,483,785 $0.00
Generate Biomedicines Inc GENB
Series A Preferred Stock · derivative
2026-03-02 Conversion 17,016,215 $0.00
Generate Biomedicines Inc GENB
Common Stock
2026-03-02 Conversion 987,491
Generate Biomedicines Inc GENB
Series A Preferred Stock · derivative
2026-03-02 Conversion 1,500,000 $0.00
Generate Biomedicines Inc GENB
Series B Preferred Stock · derivative
2026-03-02 Conversion 2,953,586 $0.00
Generate Biomedicines Inc GENB
Series B Preferred Stock · derivative
2026-03-02 Conversion 1,265,822 $0.00
Generate Biomedicines Inc GENB
Series C Preferred Stock · derivative
2026-03-02 Conversion 2,531,644 $0.00
Generate Biomedicines Inc GENB
Stock Option (Right to Buy) · derivative
2026-02-26 Grant 29,561 $0.00
Foghorn Therapeutics Inc FHTX
Series 1 Warrants to purchase Common Stock · derivative
2026-01-13 Grant 1,117,734
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com